CN Patent

CN114450287A — Shp2磷酸酶抑制剂及其制备和使用方法

Assigned to Communication Therapy Ltd · Expires 2022-05-06 · 4y expired

What this patent protects

本公开部分地涉及(R)‑1'‑(3‑(3,4‑二氢‑1,5‑萘啶‑1(2H)‑基)‑1H‑吡唑并[3,4‑b]吡嗪‑6‑基)‑3H‑螺[苯并呋喃‑2,4'‑哌啶]‑3‑胺的结晶形式、其盐及其变体。

USPTO Abstract

本公开部分地涉及(R)‑1'‑(3‑(3,4‑二氢‑1,5‑萘啶‑1(2H)‑基)‑1H‑吡唑并[3,4‑b]吡嗪‑6‑基)‑3H‑螺[苯并呋喃‑2,4'‑哌啶]‑3‑胺的结晶形式、其盐及其变体。

Drugs covered by this patent

Patent Metadata

Patent number
CN114450287A
Jurisdiction
CN
Classification
—
Expires
2022-05-06
Drug substance claim
No
Drug product claim
No
Assignee
Communication Therapy Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.